Consumer Law Library

American Bandage Corp

Volume 33 · 33 F.T.C. 1386

Citation
33 F.T.C. 1386
Docket
4354
Complaint
1940-10-22
Decision
1941-09-22
Document type
final order
Case type
consumer protection
Statutes
FTC Act (section 5)
Industry
medical bandages manufacturing
Outcome
cease and desist
Relief
cease_and_desist; compliance_reporting
Commission counsel
Mr.lllaurice 0. Pearce
Respondent counsel
Mr.' Albert I. /{egan, of Chicago, Ill
Source
Original volume PDF
Original PDF
This decision as a PDF

deceptive advertisinghealth claims

Cite this decision

American Bandage Corp, 33 F.T.C. 1386 (1941). Consumer Law Library, https://consumerlawlibrary.org/decisions/v033-0138

Report an error in this record (decision id v033-0138)

Order status: unknown. Sunset may be extended by the latest qualifying federal-court complaint alleging an order violation; complaints, dismissal/appeal outcomes, and respondent-specific extensions are not fully tracked.

Cited by 0 later FTC decisions

Cites

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF AMERICAN BANDAGE CORPORATION COMPLAINT, FINDINGS, AND ORDER IN REGARD TO TIIEl ALLEGED VIOLATION' OF' SEC. 5 OF AN ACT OF CONGRESS APPROVED SEPT. 26, 1914 Docket 4354. Complaint, Oct. 2Z, 1940-Decision, Sept. 22, 1941 \Vhere a corporation engaged in the manufacture of so-called "Self-adhering Medicated Bandages," and in the interstate sale and distribution thereof under the trade name "A B C Gauzband"; by means of advertisements dis· seminated through the mails, in newspapers and periodicals, and in circu· lars, leaflets, pamphlets, and other advertising literature, directly and indl· rectly- Represented that its product had antiseptic and germicidal properties sufficient to inhibit the growth of, and to destroy, all types of bacteria, and was self· sterilizing and remained surgically sterile after removal from the package, through such statements as ''medicated with antiseptic and germicidal ma· terial which renders it self-sterilizing • • •," "* • • will remain sterile even after it Is removed from the package," and "is safe to apply directly to the wound"· Facts being Uie ~roperties of the mercuricin medication in its said product, while antiseptic and germicidal, were insufficient to inhibit the growth of and to destroy all types of bacteria, or render such product self-sterilizing, or keep it sterile after it bad been removed from the package; With tendency and capacity to induce a substantial portion of the purchasing public to believe that such statements were true, and because of such belief, to purchase a substantial amount of its said product: Held, That such acts and practices were all to the prejudice and Injury oi' tbe public, and constituted unfair and deceptive acts and practices In commerce. Before Mr. lV. lV. Sheppard and Mr. Andrew B. Duval, trial e:s:· nminers.

Mr.lllaurice 0. Pearce for the Commission.

Mr.' Albert I. /{egan, of Chicago, Ill.,. for respondent. Complaint Pursuant to the provisions of the Federal Trade Commission .A.ct and by virtue of the authority vested in it by said act, the Federal Trade Commission, having reason to believe that American Bandage Corporation, a corporation, hereinafter referred to as the respondent, has violated the provisions of said act, and it appearing to the Com· mission that a proceeding by it in respect thereof would be in the public interest, hereby issues its complaint stating its charges in that respect as follows:

AMERICAN BANDAGE CORP. 1387 1386 Complaint PARAGRAPH 1. Respondent, American Bandage. Corporation, is a c?rporation duly chartered, organized, and existing under and by ·virtue of the laws of the State of Illinois, with its principal office and place of business located at 4238 North Lincoln Avenue, Chicago, State of Illinois.

PAn. 2. Respondent is now, and for more than 1 year last past has been, engaged in the business of manufacturing certain so-called self-adhering medicated bandages sold and distributed under the trade name and designation "A B C Gauzband," which respondent al~eges have germicidal and antiseptic properties. Respondent causes said product, when sold, to be transported from its place of business in the State of Illinois to the purchasers thereof located in the various States of the United States other than the State of Illinois and in the ~istrict of Columbia. Respondent maintains, and at all times mentioned herein has maintained, a course of trade in said products in commerce between and among the various States of the United States and in the District of Columbia.

PAR. 3. In the course and conduct of its aforesaid business, the respondent has disseminated, and is now disseminating, and has caused, and is now causing, the dissemination of false. advertisements concerning its said product by the United States mails and by various other means in commerce, as commerce is defined in the Federal Trade Colllmission Act, and has also disseminated, and is now disseminating, and has caused, and is now causing the dissemination of false advertisements concerning its said product by various means for the pur- Pose of inducing, and which are likely to induce, directly or indirectly, the purchase of its said product in commerce, as commerce is defined in the Federal Trade Commission Act. Among and typical of the false, misleading, and deceptive statements and representations contained in said false advertisements, disseminated, or caused to be disseminated, as hereinabove set forth, by the United States mails, by advertisements in newspapers and periodicals and by circulars, leaflets, pamphlets, and other advertising literature, are the following: Through the development of a secret process, used exclusively by the manufacturer, oAUZBAND is medicated with an ANTISEPTIC and oERil.nCIDAL material, rendering It self-STERILIZING. It will remain sterile even after It is removed from the llackage.

G~uzaAND is self-sterlllzlng. The manufacturer has spared no expense to make this bandage the finest of its kind In the world. Years of chemical research have lllade possible the development of a new, secret process used exclusively by the lllanufacturer to render oAUZBAND self-sterlllzlng; It will remain sterile even after It Is removed from the package.

Findings 33F. T. C.

The same process used in rendering GAUZBAND self-sterilizing, which is done with a medication containing antiseptic and germicidal materials, also makes it antiseptic and impregnates it with germicidal properties. ABo GAUZBAND is a pure white cohesive gauze bandage offering maximum protection because it is medicated with antiseptic and germicidal material which renders it self-sterilizing, assuring the user a surgically sterile dressing. It iS safe to apply directly to the wound.

PAR. 4. Through the use of the statements hereinabove set forth, and others similar thereto not specifically set out herein, respondent bas represented and does now represent, directly and indirectly, that its said product has been impregnated with certain materials which give said product antiseptic and germicidal properties sufficient to inhibit the growth of, and to destroy all types of bacteria, thereby making eaid product self-sterilizing and causing it to remain surgically sterile after it has been removed from the package. PAR. 5. The aforesaid claims, statements and representations as hereinabove described are grossly exaggerated, false and misleading. In truth and in fact, respondent's product is not self-sterilizing and will not remain sterile after it has·been removed from the package. The medication in said product consists of mercuricine, which is a mer· cury salt derivative, having antiseptic and mild germicidal properties. These properties, however, are insufficient to inhibit the growth of and to destroy all types of bacteria or to render respondent's product self· sterilizing or keep respondent's product surgically sterile after it bas been removed from the package.

PAR. 6. The use by the respondent of the foregoing false, mislend· ing, and deceptive statements, representations, and advertisements, disseminated as aforesaid, with respect to the properties of its product, has had and now has the tendency and capacity to mislead and deceive a substantial portion of the purchasing public into the erroneous and mistaken belief that such false statements, representations, and adver· tisements are true, and to induce a substantial portion of the purchas· ing public, because of such erroneous and mistaken belief, to purchase a substantial amount of respondent's product. PAR. 7. The aforesaid acts and practices of the respondent, as here· inabove set forth, are all to the prejudice and injury of the public, and constitute unfair and deceptive acts and practices in commerce within the intent and meaning of the Federal Trade Commission Act. REPORT, FINDINGS AS TO THE FACTs, AND ORDER Pursuant to the provisions of the Federal Trade Commission Act, the Federal Trade Commission, on the 22d day of October 1940, issued and thereafter served its complaint in this proceeding upon AMERICAN BANDAGE CORP. 1389 1386 Findings the respondent American Bandage Corporation, a corporation, charging it with unfair and deceptive acts and pr~1ctices in comlnerce, in violation of the provisions of said act. AftEor·the issuance of the complaint and the filing of respondent's answer thereto, evidence in support of the allegations of the complaint was introduced by the attorney for the Commission, at a hearing helc!. before a duly appointed trial examiner of the Commission designated by it to serve in this proceeding, and at said hearing a stipulation as to the facts was entered into between the attorney for the Commission and the attorney for the respondent, and at a later date the attorney for respondent waived the filing of briefs and oral argument, and agreed that the case be submitted to the Commission upon the record. The evidence introduced and the stipulation as to the facts were duly recorded and filed in the office of the Commission. Thereafter, the proceedings regularly came on for final hearing before the Commission on the complaint, the answer thereto, the evidence, the stipulation as to the facts, the trial examiner's report upon the evidence and brief in support of the complaint; and the Commission, having duly considered the matter and being now fully advised in the premises, finds that this proceeding is in the interest of the public, and makes this its findings as to the facts and. its conclusion drawn therefrom. . · FINDINGS AS TO Tile FACTS PARAGRAPH 1. Respondent, American Bandage Corporation, is a corporation organized under the laws of the State of Illinois, with its principal office and place of business at 1701 Damen Avenue, Chicago, Ill.

PAR. 2. Respondent, for some time prior to the Issuance of the complaint herein had .been and now is engaged in the business o£ :manufacturing certain so-called "Self-adhering Medicated Bandages," and in the sale and distribution of same under the trade name and designation "A B C Gauzband,'' and caused and causes said Product, when sold, to be shipped from its place of business to purchasers thereof located in various States of the United States and in the District of Columbia.

Respondent maintains and has maintained a course of tmde in its said products in commerce between.n and among various States of the United States and in the District of Columbia. PAR. 3. Respondent, in the conduct of its business has disseminated, and has caused the dissemination of advertisements concerning its products by means of the United States mails and by various other means. in commerce .as "commerce" is defined in the Federal Trade 43GG26m--42--vo1.83----88 l Findings 33F. T.C.

Commission Act, and has also disseminated and caused the disseroi· nation of advertisements concerning its products by various means, for the purpose of inducing and which are likely to induce, directly or indirectly, the purchase of its product in commerce as "commerce" is defined in the Federal Trade Commission Act. Among and typical of the statements and representations con· tained in the advertisements disseminated or caused to be disseroi· nated by respondent by means of the United States mails, by advertisements in newspapers, periodicals and by circulars, leaflets, pamphlets and other advertising literature, are the following: Through the development of a secret process used exclusiv(ly by the manufacturer, GAUZBAND is medicated with an ANTISEPTIC and GEP.MICIDAL material, rendering it self-STEIULIZING. It will remain sterile even after it is removed from the package.

GAUZBAND is self-sterllizing. The mlmufacturer has spared no expense to make this bandage the finest of its kind in the world. Years of chemical research have made possible the development of a new, secret process used exclusively by tb.e manufacturer to render G.AUZBAND self-sterilizing; it will remain sterile even after it is removed from the package. The same pt·ocess used in ren<lering GAUZBAND self-sterilizing, which is done with a medication containing antiseptic and germicidal materials, also lllakeS it antiseptic and impregnates it with germicidal properties . .ADC GAUZD.AND is a pure white cohesive gauze bandage offering maximum protection because it is medicated with. antiseptic and germicidal material which renders it self-sterilizing, assuring the user a .surgically sterile dressing. It is safe to apply directly to the wound.

PAn. 4. Through the use of the statements set forth in paragraph 3 hereof, and others similar to the above but not herein set out, respondent has represented, directly and indirectly, that its product has been impregnated with certain materials which give it anti· septic and germicidal properties sufficient to inhibit the growth of, and to destroy, all types of bacteria, thereby making the product self· sterilizing and causing it to remain surgically sterile after it has been removed from the package.

PAR. 5. The statements and representations made by the respondent, as set forth in paragraph 3, and others referred to in paragraph 4, hereof, are false, misleading, and deceptive, in that respondent's product is not self-sterilizing and will not remain sterile after it has been removed from the package. The medication in respondent's product consists of mercuricin, which is an organic mercury salt having antiseptic and germicidal properties. These properties are insufficient to inhibit the growth of and to destroy all types of hac· teria, or to render respondent's product self-sterilizing, or to keep respondent's product surgically sterile after it has been removed froro the package.

A.."\ierican BANDAGE CORP. 1391 1386 Order PAn. 6. The use by respondent of the statements, representations, and advertisements set out in paragraph 3 and referred to in paragraph 4, with respect to the properties of its product, has had the tendency and capacity to induce a substantial portion of the purchasing public to believe that such statements, representations, !lnd advertisements are true, and to induce a substantial portion of the purchasing public because of such belief, to purchase a substantial amount of respondent's product.

CONCLUSION The aforesaid acts and practices of the respondent are all to the Prejudice and injury of the public, and constitute unfair and deceptive acts and practices in commerce, within the intent and meaning of the Federal Trade Commission Act.

ORDER TO CEASE AND DESIST This proceeding having been heard by the Federal Trade Comtnission upon the complaint of the Commission, the answer of the respondent, evidence introduced before a duly appointed trial examiner of the Commission designated by it to serve in this proceeding, the report of tlle trial examiner thereon, the stipulation as to the facts entered into between the attorney for the Commission and the attorney for respondent, and brief filed on behalf of the Comtnission; and the Commission having made its findings as to the facts and its conclusion that the respondent has violated the provisions of the Federal Trade Commission Act.

It is ordel•ed, That the respondent, American Bandage Corporation, a corporation, its officers, directors, agents, representatives, and employees, jointly or severally, directly or through any corporate or other device, in connection with the offering for sale, sale and distribution of any medicated bandage sold and distributed by it under the trade name "A B C Gauzband," or under any other trade name or designation, do forthwith cease and desist from, directly or indirectly :

1. Disseminating, or causing to be disseminated, any advertisement in newspapers, periodicals, circulars, leaflets, pamphlets, or otherwise, by means of the United States mails, or by any means, in commerce as "commerce" is defined in the Federal Trade Commission Act, which advertisement represents, directly or by implication, that its said product possesses antiseptic and germicidal properties sufficient to inhibit the growth of, or to destroy, all types of bacteria, or which represents, directly or indirectly, that said product is a 1392 FEDERAL TRADE CO.MMISSIO~ DECISIONS Order 83F.T.C· sterilizing agent, or that it remains sterile after it has been removed from the container.

· 2. Disseminating, or causing to be disseminated, any advertisement in newspapers, periodicals, circulars, leaflets, pamphlets, or otherwise, by any means, for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase in commerce, as "commerce" is defined in the Federal Trade Commission Act, of respondent's said product, which advertisement contains any of the representations prohibited in paragraph 1 hereof. It i8 further Ordered, That respondent shall, within 60 days after service upon it of this order, file with the Commission a report in writing, setting forth in detail the manner and form in which it has complied with this order.

WSE!PH WARNER FURNITURE CORP. 1393 Syllabus

← 33 F.T.C. 1378 · 33 F.T.C. 1393 →